BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16213790)

  • 1. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
    Hol EM; van Leeuwen FW; Fischer DF
    Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-proteasome system and Parkinson's disease.
    Olanow CW; McNaught KS
    Mov Disord; 2006 Nov; 21(11):1806-23. PubMed ID: 16972273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does smoking reduce the risk of Parkinson's disease through stimulation of the ubiquitin-proteasome system?
    Chapman MA
    Med Hypotheses; 2009 Dec; 73(6):887-91. PubMed ID: 19540050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global changes to the ubiquitin system in Huntington's disease.
    Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
    Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misframed proteins and neurodegeneration: a novel view on Alzheimer's and Parkinson's diseases.
    Dennissen FJ; Kholod N; Steinbusch HW; Van Leeuwen FW
    Neurodegener Dis; 2010; 7(1-3):76-9. PubMed ID: 20173331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEDD8 protein is involved in ubiquitinated inclusion bodies.
    Dil Kuazi A; Kito K; Abe Y; Shin RW; Kamitani T; Ueda N
    J Pathol; 2003 Feb; 199(2):259-66. PubMed ID: 12533840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system.
    de Vrij FM; Fischer DF; van Leeuwen FW; Hol EM
    Prog Neurobiol; 2004 Dec; 74(5):249-70. PubMed ID: 15582222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
    Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
    Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches.
    Paul S
    Bioessays; 2008 Nov; 30(11-12):1172-84. PubMed ID: 18937370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling proteasome dynamics in Parkinson's disease.
    Sneppen K; Lizana L; Jensen MH; Pigolotti S; Otzen D
    Phys Biol; 2009 May; 6(3):036005. PubMed ID: 19411740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
    Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
    Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.
    Lim KL
    Expert Rev Proteomics; 2007 Dec; 4(6):769-81. PubMed ID: 18067415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-dependent and -independent mitochondrial protein quality controls: implications in ageing and neurodegenerative diseases.
    Germain D
    Mol Microbiol; 2008 Dec; 70(6):1334-41. PubMed ID: 19019155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-proteasome system in Huntington's disease.
    Valera AG; Díaz-Hernández M; Hernández F; Ortega Z; Lucas JJ
    Neuroscientist; 2005 Dec; 11(6):583-94. PubMed ID: 16282599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin.
    Fischer DF; van Dijk R; van Tijn P; Hobo B; Verhage MC; van der Schors RC; Li KW; van Minnen J; Hol EM; van Leeuwen FW
    Neurobiol Aging; 2009 Jun; 30(6):847-63. PubMed ID: 18760506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.